CXCR4 and breast carcinoma: The CXCL signaling pathway not only plays a key role in gastric cancer immune resistance [64], but also induces EMT progression vis the CXCL12-CXCR4 axis [65], the role of which has also been confirmed in breast cancer metastasis [66].